Recently, A2M has been shown to influence tumour cell adhesion, migration, and growth by inhibiting tumour-promoting signalling pathways, e.g., PI3K/AKT and SMAD, and upregulating PTEN [29]. This evidence concerns the gene AKT1 and neoplasm.